Insider Selling: Jimenez Juan Jose Roman Sells 1,700 Shares of Evotec AG Stock (EVTC)
Evotec AG (NASDAQ:EVTC) CFO Jimenez Juan Jose Roman sold 1,700 shares of Evotec AG stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $24.00, for a total value of $40,800.00. Following the sale, the chief financial officer now directly owns 244,053 shares in the company, valued at approximately $5,857,272. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Shares of Evotec AG (NASDAQ:EVTC) traded up 0.21% on Thursday, hitting $23.90. The stock had a trading volume of 627,810 shares. Evotec AG has a 52 week low of $19.50 and a 52 week high of $26.33. The stock has a 50-day moving average of $23.38 and a 200-day moving average of $23.82. The company’s market cap is $1.873 billion.
Evotec AG (NASDAQ:EVTC) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.40 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.39 by $0.01. The company had revenue of $87.20 million for the quarter, compared to the consensus estimate of $91.26 million. Evotec AG’s revenue was down .1% compared to the same quarter last year. Analysts expect that Evotec AG will post $1.68 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Friday, June 6th. Shareholders of record on Monday, May 19th will be given a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 1.67%. The ex-dividend date of this dividend is Thursday, May 15th.
Evotec AG is a Germany-based parent company of the Evotec group, which is engaged in drug discovery and development company focused on providing integrated drug discovery services and alliances to the pharmaceutical and biotechnology industry.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.